| Product Code: ETC10815319 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Cyprus continued to rely heavily on India, Greece, Italy, Netherlands, and Belgium for small molecule CDMO imports. Despite a high Herfindahl-Hirschman Index (HHI) indicating market concentration, the industry experienced a negative Compound Annual Growth Rate (CAGR) of -2.73% from 2020 to 2024. The growth rate plummeted further in 2024, with a significant decline of -43.9% compared to the previous year. This trend suggests challenges and potential shifts in the small molecule CDMO import market in Cyprus, warranting further analysis and strategic considerations for industry players.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Cyprus Small Molecule CDMO Market Overview |
3.1 Cyprus Country Macro Economic Indicators |
3.2 Cyprus Small Molecule CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 Cyprus Small Molecule CDMO Market - Industry Life Cycle |
3.4 Cyprus Small Molecule CDMO Market - Porter's Five Forces |
3.5 Cyprus Small Molecule CDMO Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
3.6 Cyprus Small Molecule CDMO Market Revenues & Volume Share, By API Type, 2021 & 2031F |
3.7 Cyprus Small Molecule CDMO Market Revenues & Volume Share, By Drug Development Stage, 2021 & 2031F |
3.8 Cyprus Small Molecule CDMO Market Revenues & Volume Share, By Facility Type, 2021 & 2031F |
3.9 Cyprus Small Molecule CDMO Market Revenues & Volume Share, By Regulatory Compliance, 2021 & 2031F |
4 Cyprus Small Molecule CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Cyprus Small Molecule CDMO Market Trends |
6 Cyprus Small Molecule CDMO Market, By Types |
6.1 Cyprus Small Molecule CDMO Market, By Service Type |
6.1.1 Overview and Analysis |
6.1.2 Cyprus Small Molecule CDMO Market Revenues & Volume, By Service Type, 2021 - 2031F |
6.1.3 Cyprus Small Molecule CDMO Market Revenues & Volume, By Drug Substance Development, 2021 - 2031F |
6.1.4 Cyprus Small Molecule CDMO Market Revenues & Volume, By Drug Product Manufacturing, 2021 - 2031F |
6.1.5 Cyprus Small Molecule CDMO Market Revenues & Volume, By Formulation Services, 2021 - 2031F |
6.1.6 Cyprus Small Molecule CDMO Market Revenues & Volume, By Analytical Testing, 2021 - 2031F |
6.1.7 Cyprus Small Molecule CDMO Market Revenues & Volume, By Packaging & Logistics, 2021 - 2031F |
6.2 Cyprus Small Molecule CDMO Market, By API Type |
6.2.1 Overview and Analysis |
6.2.2 Cyprus Small Molecule CDMO Market Revenues & Volume, By Generic APIs, 2021 - 2031F |
6.2.3 Cyprus Small Molecule CDMO Market Revenues & Volume, By Specialty APIs, 2021 - 2031F |
6.2.4 Cyprus Small Molecule CDMO Market Revenues & Volume, By Biotech APIs, 2021 - 2031F |
6.2.5 Cyprus Small Molecule CDMO Market Revenues & Volume, By Oncology Drug APIs, 2021 - 2031F |
6.2.6 Cyprus Small Molecule CDMO Market Revenues & Volume, By High-Potency APIs, 2021 - 2031F |
6.3 Cyprus Small Molecule CDMO Market, By Drug Development Stage |
6.3.1 Overview and Analysis |
6.3.2 Cyprus Small Molecule CDMO Market Revenues & Volume, By Early-Stage Discovery, 2021 - 2031F |
6.3.3 Cyprus Small Molecule CDMO Market Revenues & Volume, By Preclinical Trials, 2021 - 2031F |
6.3.4 Cyprus Small Molecule CDMO Market Revenues & Volume, By Clinical Trials Phase 1, 2021 - 2031F |
6.3.5 Cyprus Small Molecule CDMO Market Revenues & Volume, By Commercial Manufacturing, 2021 - 2031F |
6.3.6 Cyprus Small Molecule CDMO Market Revenues & Volume, By Post- Surveillance, 2021 - 2031F |
6.4 Cyprus Small Molecule CDMO Market, By Facility Type |
6.4.1 Overview and Analysis |
6.4.2 Cyprus Small Molecule CDMO Market Revenues & Volume, By Pilot Scale, 2021 - 2031F |
6.4.3 Cyprus Small Molecule CDMO Market Revenues & Volume, By Large-Scale Production, 2021 - 2031F |
6.4.4 Cyprus Small Molecule CDMO Market Revenues & Volume, By R&D Facilities, 2021 - 2031F |
6.4.5 Cyprus Small Molecule CDMO Market Revenues & Volume, By Sterile Manufacturing Units, 2021 - 2031F |
6.4.6 Cyprus Small Molecule CDMO Market Revenues & Volume, By Integrated Supply Chain Management, 2021 - 2031F |
6.5 Cyprus Small Molecule CDMO Market, By Regulatory Compliance |
6.5.1 Overview and Analysis |
6.5.2 Cyprus Small Molecule CDMO Market Revenues & Volume, By US FDA & EMA Approved, 2021 - 2031F |
6.5.3 Cyprus Small Molecule CDMO Market Revenues & Volume, By GMP & ISO 13485 Certified, 2021 - 2031F |
6.5.4 Cyprus Small Molecule CDMO Market Revenues & Volume, By WHO GMP Standards, 2021 - 2031F |
6.5.5 Cyprus Small Molecule CDMO Market Revenues & Volume, By Good Laboratory Practices, 2021 - 2031F |
6.5.6 Cyprus Small Molecule CDMO Market Revenues & Volume, By Hazardous Material Handling, 2021 - 2031F |
7 Cyprus Small Molecule CDMO Market Import-Export Trade Statistics |
7.1 Cyprus Small Molecule CDMO Market Export to Major Countries |
7.2 Cyprus Small Molecule CDMO Market Imports from Major Countries |
8 Cyprus Small Molecule CDMO Market Key Performance Indicators |
9 Cyprus Small Molecule CDMO Market - Opportunity Assessment |
9.1 Cyprus Small Molecule CDMO Market Opportunity Assessment, By Service Type, 2021 & 2031F |
9.2 Cyprus Small Molecule CDMO Market Opportunity Assessment, By API Type, 2021 & 2031F |
9.3 Cyprus Small Molecule CDMO Market Opportunity Assessment, By Drug Development Stage, 2021 & 2031F |
9.4 Cyprus Small Molecule CDMO Market Opportunity Assessment, By Facility Type, 2021 & 2031F |
9.5 Cyprus Small Molecule CDMO Market Opportunity Assessment, By Regulatory Compliance, 2021 & 2031F |
10 Cyprus Small Molecule CDMO Market - Competitive Landscape |
10.1 Cyprus Small Molecule CDMO Market Revenue Share, By Companies, 2024 |
10.2 Cyprus Small Molecule CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here